Jazz Pharmaceuticals plc buy SVB Leerink LLC
Start price
22.04.26
/
50%
€171.20
Target price
22.04.27
€191.59
Performance (%)
25.35%
Price
17.08.26
€214.60
Summary
This prediction is currently active. The prediction currently has a performance of 25.35%. This prediction currently runs until 22.04.27. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Jazz Pharmaceuticals plc | -3.377% | -3.377% |
| iShares Core DAX® | -0,05 % | 5,96 % |
| iShares Nasdaq 100 | 0,92 % | 3,69 % |
| iShares Nikkei 225® | 3,01 % | 6,64 % |
| iShares S&P 500 | -0,36 % | 2,75 % |
Comments by SVB_Leerink_LLC for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals (JAZZ) had its price target raised by Leerink Partners from $215.00 to $225.00. They now have an "outperform" rating on the stock.
Ratings data for JAZZ provided by MarketBeat

